John Power

Electrophysiology fellow @MountSinaiHeart. Views are mine

[CircEP @CirculationEP]

Interface temp rises during lattice-tip PFA vary by site, with RSPV often blunted. Temp rise correlates with lesion depth—real-time feedback? @johnpowermd @jskoruth #Epeeps @VivekReddyMD @DrKeitaW https://t.co/gaULlUTRBY

[Benay Ozbay @benayozbay]

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology https://t.co/2Gt2Oj6DxG @DrJESalem @CardioOncology @JohnPowerMD

[John Power @JohnPowerMD]

Dr. Hu is building something big!

[Chittur Sivaram MD MACP MACC @CASivaram1]

#OUCVGR
🎖️Delighted to welcome a “pre-early career faculty” speaker at our next OU CV Grand Rounds on 11/20/25
🎖️Dr. Jiun-Ruey MD MPH, currently a structural interventional fellow at Cedars Sinai will discuss ‘Building tools for CV MedEd in the digital age”
🎖️Join us⬇️

https://t.co/hJvf3BGNAA

@OUCollegeofMed
@ruey_hu
@DrJMarine
@ShashankSinhaMD
@HeartOTXHeartMD
@iamritu
@SumeetSChugh
@DineshKalra
@MKIttlesonMD
@DrMarthaGulati
@MarkBelkinMD

[John Power @JohnPowerMD]

@CardioOncology @DrJESalem @UCSDCardFellows @UCSDCardiology @DLBHATTMD @MountSinaiHeart @IcahnMountSinai @MSMCardsFellows Proud to have been a part of this! Couldn't have happened without you and all the contributors to our International ICI-Myocarditis Registry

[John Power @JohnPowerMD]

At last—our analysis predicting severe outcomes in ICI-myocarditis is out. With just ECG, LVEF, troponin, and clinical history, you can estimate risk at initial presentation. Grateful for the incredible mentorship @CardioOncology @DrJESalem .. true world-class investigators!

[Javid Moslehi @CardioOncology]

Excited to report this important collaboration which we hope helps us understand ICI-myocarditis better, published in #EHJ today! Along with the great @DrJESalem! @ehj_ed @JBauersachsMD #CardioOnc @UCSFCardiology @UCSFCancer

https://t.co/3jsZaZ2SuQ

[John Power @JohnPowerMD]

🚨Out now in @ESC_Journals 🚨- Our review on the growing use of AI/digital tools in cardiology trials! Lots of opportunities (also pitfalls) for CV researchers. Thx to @CVCTForum & my awesome co-authors @lamcardio @FaiezZANNAD @ruey_hu.
📖 Read it here: https://t.co/Zcl58lHCKo

[EHJ Editor-in-Chief @ehj_ed]

Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials. Read more in EHJ.
https://t.co/cIVCTKYagL
@ESCardio @ESC_Journals #AI #RCT @JohnPowerMD, @ruey_hu, @lamcardio, @FaiezZANNAD

[Medtronic Cardiac @MDT_Cardiac]

Congratulations to Dr. Srinivas Dukkipati & Dr. Vivek Reddy at Mt. Sinai Hospital in NYC for their first cases with the Affera™ Mapping and Ablation System & all-in-one, dual energy, Sphere-9™ catheter. Learn more:
https://t.co/JjPsEve2ih See risk info: https://t.co/UJynHx6nAH

[John Power @JohnPowerMD]

Learned a lot at @HRS2024 sharing @UCSDCardiology experience identifying and treating crux VTs with ablation at the CS os @GordonHo_EP

[John Power @JohnPowerMD]

Massive achievement by @kevingbuell who used ML to personalize ICU care where RCTs haven't found benefit - O2 goals! Exciting work from this star @VUMCMedicineRes coresident

[Kevin Buell @kevingbuell]

Incredible unforgettable week at #ISICEM24. Hopefully doi:10.1001/jama.2024.2933 can bring us closer to evidence based + personalized medicine. Thank you to @fabio_taccone @jlvincen @seymoc @JAMA_current for inviting us. Don't miss Derek Angus editorial doi:10.1001/jama.2024.0972

[John Power @JohnPowerMD]

Look at this treasure trove of data on arrhythmic mitral valve prolapse coming from sub studies of the #PRIMARY trial - TEER vs primary repair for degenerative MR @CVCTForum @MountSinaiHeart @CTSN16

[John Power @JohnPowerMD]

@miltonpacker shows proposed changes which turn the SUMMIT trial to a HFpEF outcomes trial for #glp1 agonists , inspired by death and hf signals from STEP-HFpEF @CVCTForum

[Ruey Hu, MD, MPH @ruey_hu]

Only 1 in 8 patients with cardiovascular disease are diagnosed before the onset of symptoms, Dr @rohan_khera notes @CVCTForum.

Work from @cards_lab @YaleCardiology by @LovedeepDhingra @ekoikonomou @PhyllisTweets @Veer_Sangha_ @AryaAminorroaya @aakhunte has shown that #AIECG can augment human capacity to identify pre-symptomatic disease, including LV systolic dysfunction, HCM, amyloid, and severe valve disease.

Scalable deployment of AI-ECG can enhance patient discovery, detect disease, and monitor response to trials.

[John Power @JohnPowerMD]

@ruey_hu

[John Power @JohnPowerMD]

@CVCTForum off to a great start -@charis_antoniad demonstrates how digital biomarkers can serve as trial endpoints - #AI derived CCTA scores the ‘golden bullet’ for future CAD studies? @lamcardio @hmkyale

[John Power @JohnPowerMD]

@CVCTForum off to a great start - exciting demonstration by @charis_antoniad of the potential for digital biomarkers to enhance trial endpoints , #AI derived FAI-score from CCTA , the ‘golden bullet’ for future trials?

[John Power @JohnPowerMD]

Elated to be joining @MountSinaiHeart for EP fellowship next year!! Can’t wait! #EPeeps #Match2024

[UC San Diego Cardiology @UCSDCardiology]

Poster presentation by fellow @JohnPowerMD with mentor Dr. Green on transvenous lead extraction at time of device upgrade. @UCSDCardFellows #AHA23

[UC San Diego Cardiology @UCSDCardiology]

Congratulations to third year fellow @JohnPowerMD on his new publication @NatureMedicine.

ICI-myocarditis incidence and severity is associated with thymic cancer and thymic dysfunction
@UCSDCardFellows @ucsdim @UCSDHealth

https://t.co/JwBPCRGyc4